Average Co-Inventor Count = 4.26
ph-index = 51
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Maxygen, Inc. (38 from 124 patents)
2. Dna Twopointo Inc. (29 from 33 patents)
3. Pioneer Hi-bred International, Inc. (13 from 6,488 patents)
4. Codexis Mayflower Holdings, LLC (13 from 19 patents)
5. E.i. Dupont De Nemours and Company (6 from 16,338 patents)
6. E. I. Du Pont De Nemours (6 from 27 patents)
7. Pfizer Corporation (4 from 4,452 patents)
8. Other (3 from 832,398 patents)
9. Novozymes A/s (3 from 1,370 patents)
10. Codexis, Inc. (3 from 456 patents)
11. Pioneer Hi-bred Int'l Inc. (3 from 20 patents)
12. Butamax Advanced Biofuels LLC (2 from 124 patents)
13. Pfizer Products Inc. (2 from 47 patents)
14. Calysta, Inc. (2 from 31 patents)
15. The General Hospital Corporation (1 from 2,862 patents)
123 patents:
1. 12419913 - Modification of CAR-T cells
2. 12404504 - Transposition of nucleic acids into eukaryotic genomes with a transposase from heliothis
3. 12351800 - Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products
4. 12351813 - Tetracycline-inducible expression system
5. 12122995 - DNA vectors, transposons and transposases for eukaryotic genome modification
6. 12054702 - DNA vectors, transposons and transposases for eukaryotic genome modification
7. 11845936 - Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products
8. 11713468 - DNA vectors and elements for sustained gene expression in eukaryotic cells
9. 11566262 - Tetracycline-inducible expression systems
10. 11401521 - Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias
11. 11396662 - Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois
12. 11162102 - Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products
13. 11060098 - Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias
14. 11060109 - Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois
15. 11060086 - Transposition of nucleic acids into eukaryotic genomes with a transposase from heliothis